Reckitt Benckiser Group (LON:RKT) Announces Quarterly Earnings Results

Reckitt Benckiser Group (LON:RKT - Get Free Report) issued its quarterly earnings data on Thursday. The company reported GBX 349.70 ($4.53) EPS for the quarter, Digital Look Earnings reports. Reckitt Benckiser Group had a net margin of 10.78% and a return on equity of 18.70%.

Reckitt Benckiser Group Stock Performance

RKT traded down GBX 100 ($1.29) on Tuesday, reaching GBX 5,264 ($68.15). The stock had a trading volume of 254,434,031 shares, compared to its average volume of 12,901,748. The business's 50-day moving average price is GBX 5,139.43 and its two-hundred day moving average price is GBX 4,851.55. The company has a market cap of £35.91 billion, a P/E ratio of 24.09, a price-to-earnings-growth ratio of 1.10 and a beta of 0.09. Reckitt Benckiser Group has a 12-month low of GBX 4,034 ($52.23) and a 12-month high of GBX 5,418 ($70.15). The company has a current ratio of 0.69, a quick ratio of 0.46 and a debt-to-equity ratio of 110.26.

Reckitt Benckiser Group Company Profile

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.